Yi Shi

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

Joaquim Bellmunt, Maha Hussain, Jürgen E. Gschwend et al. · The Lancet Oncology · 2021 · 412 citations · Full text

Medicine, Oncology, Pharmacology +12

Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials.

Jianping Liu, Jing Zhang, Yi Shi et al. · Chinese Medicine · 2006 · 235 citations · Full text

Pharmacy, Nutritional Sciences, Pharmacotherapy +14

Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis

Wei Zhou, Hongxing Li, Yan Zhang et al. · Journal of Clinical Microbiology · 2017 · 205 citations · Full text

Medicine, Infectious Diseases, Pathology +17

Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China

Jieming Qu, Jing Zhang, Yu Chen et al. · Emerging Microbes & Infections · 2022 · 135 citations · Full text

Veterinary Medicine, Community Health, Infectious Diseases +17

Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

Thomas Powles, Zoe J. Assaf, Viraj Degaonkar et al. · European Urology · 2023 · 131 citations

Medicine, Oncology, Pharmacology +16